Treosulfan Completed Phase 2 Trials for Myelodysplastic Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01062490Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)